| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Former Director
4 companies
Schmid John P. is a Director at AnaptysBio, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 7 buys and 3 sells.
Estimated insider holdings value: $3.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | ANAB Anaptysbio, Inc. | Director | Sell | 20,645 | $56.11 | $1,158,451.42 | -16.6% | - | - | |
| Aug 12, 2024 | XERS Xeris Biopharma Holdings, Inc. | Director | Buy | 4,515 | $2.25 | $10,147.01 | +21.8% | +45.8% | +224.4% | |
| Aug 9, 2024 | XERS Xeris Biopharma Holdings, Inc. | Director | Buy | 4,285 | $2.37 | $10,134.03 | +26.1% | +44.8% | +194.8% | |
| May 10, 2024 | XERS Xeris Biopharma Holdings, Inc. | Director | Buy | 5,400 | $1.91 | $10,314.00 | +49.1% | +26.7% | +184.7% | |
| Mar 25, 2024 | DSGN Design Therapeutics, Inc. | Director | Buy | 26,965 | $3.70 | $99,738.48 | +294.5% | -10.2% | +22.7% | |
| Mar 14, 2024 | XERS Xeris Biopharma Holdings, Inc. | Director | Buy | 4,500 | $2.16 | $9,720.00 | +69.2% | +5.2% | +126.3% | |
| Nov 16, 2023 | XERS Xeris Biopharma Holdings, Inc. | Director | Buy | 6,500 | $1.51 | $9,815.00 | New | +104.5% | +86.0% |